Cohort studyindependent cross-checkabstract checked★ key study I-VEG-102 in-depth review

Week-to-week vitamin K swings move INR

Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.

Overview

Couris R et al.. Int J Vitam Nutr Res 2006 · PMID 16941417 · DOI 10.1024/0300-9831.76.2.65

A weekly change of about 714 micrograms of vitamin K changed INR by about one unit in 43 new warfarin users.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Quantify the effect of vitamin K variability on INR.

How was the study done?

Daily food records and weekly INR for 5 weeks.

How many people, animals or samples were studied?

43 completers.

What was actually found?

Bigger swings in vitamin K went with bigger swings in INR.

How large was the observed effect?

714 ug/week per 1 INR unit; r = -0.60.

What do the results mean in everyday life?

Eating very different amounts of greens from week to week can make INR unstable.

What are the study's limitations?

Small, short, early-treatment phase.

What does it say about Elawady's specific claim?

Supports "changes in greens intake affect warfarin", not "greens must be avoided".

Do the results apply to Germany and Europe?

Applies to all VKA users.

What can explicitly not be concluded from this study?

Cannot show that consistent greens intake is harmful.

Scientific in-depth review

1. Full reference

Authors
Couris R et al.
Journal
Int J Vitam Nutr Res
Year
2006
Identifier
PMID 16941417 DOI 10.1024/0300-9831.76.2.65
Verification
verified – PubMed efetch 2026-10-26; Crossref 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

How much does week-to-week variability in dietary vitamin K change INR in patients starting warfarin?

3. Study design and population

Study design
Cohort study – Prospective dietary-assessment cohort with weekly INR, 5 weeks
Population

Outpatients who began warfarin within 14 days, Massachusetts General Hospital

Country

USA

Period

not stated in abstract

Sample size

60 enrolled, 43 completed

Inclusion and exclusion criteria

Excluded >2 alcoholic drinks/day, non-English speakers, liver disease, terminal illness

4. Methods and endpoints

Exposure / intervention

Week-to-week change in dietary vitamin K1 (validated self-monitoring tool)

Comparator

Within-person variation

Endpoints

Weekly INR

Statistical methods

Pearson correlation; multiple regression adjusted for age, sex, weight, height, interacting medications

5. Actual results

Results

Variability in INR inversely correlated with change in vitamin K intake (r = -0.600, p < 0.01). A weekly change of 714 ug dietary vitamin K altered weekly INR by 1 unit (p < 0.01); 14.5 mg warfarin per week altered INR by 1 unit.

Absolute risks

not reported

Authors' conclusion

Patients taking warfarin and consuming markedly changing amounts of vitamin K may have a variable weekly INR with potentially unstable anticoagulant outcomes.

6. Strengths

  • Prospective daily food records
  • Quantitative dose-response estimate
  • Adjusted for interacting medications

7. Weaknesses

  • Small; 28% drop-out
  • Short follow-up
  • Early warfarin phase (dose titration may confound)
  • Single centre

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Confounding by dose adjustments and drop-out possible.

9. Assessment of the statistical interpretation

714 ug/week corresponds to ~102 ug/day sustained change per INR unit (stats/C-VEG-12_warfarin.py); regression model R 0.848 includes warfarin dose.

10. Relevance to the specific claim

Direct: quantifies the effect of CHANGING vitamin K intake on INR.

11. Independent contrary findings

Dentali 2016 and Sconce 2007: low and unstable intake rather than high intake per se linked to instability.

12. Transferability to Germany and Europe

Universal pharmacology.

13. Overall methodological judgement

Supports the conditional claim (variability in intake affects INR).

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Replication in larger cohorts with stable maintenance doses.

15. Linked fact checks